Clinical Trial Update: Multi-center Study to Assess Safety, Tolerability and Efficacy of Topical Pravibismane in Moderate DFI Patients [Phase 2]

View source ↗

Summary

A Phase 2 multi-center study evaluating the safety, tolerability, and efficacy of topical pravibismane in adults with moderate diabetic foot infection; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot
• Diabetic Foot Infection

Drugs mentioned

• Pravibismane (topical) (pravibismane)

Snippet

Sponsor: Microbion Corporation | Conditions: Diabetic Foot Infection, Diabetic Foot | Phase 2 | Status: COMPLETED